相似文献
1
Positive light on schizophrenia and aging: Commentary on course and predictors of symptomatic remission in schizophrenia: A 5-year follow-up study in a Dutch psychiatric catchment area, by Lange et al.
Schizophr Res. 2019 Sep;211:32-33. doi: 10.1016/j.schres.2019.07.037. Epub 2019 Aug 1.
2
Course and predictors of symptomatic remission in late-life schizophrenia: A 5-year follow-up study in a Dutch psychiatric catchment area.
Schizophr Res. 2019 Jul;209:179-184. doi: 10.1016/j.schres.2019.04.025. Epub 2019 May 9.
3
Symptomatic remission and associated factors in a catchment area based population of older patients with schizophrenia.
Schizophr Res. 2011 Mar;126(1-3):237-44. doi: 10.1016/j.schres.2010.09.003.
4
Remission in schizophrenia: a community-based 6-year follow-up study in Bali.
Psychiatry Clin Neurosci. 2011 Aug;65(5):476-82. doi: 10.1111/j.1440-1819.2011.02246.x.
5
Symptomatic remission and cognitive impairment in first-episode schizophrenia: a prospective 3-year follow-up study.
J Clin Psychiatry. 2013 Nov;74(11):e1046-53. doi: 10.4088/JCP.13m08355.
6
One-year functional outcomes of naturalistically treated patients with schizophrenia.
Psychiatry Res. 2012 Aug 15;198(3):378-85. doi: 10.1016/j.psychres.2011.12.047. Epub 2012 Mar 14.
7
Symptomatic remission affects employment outcomes in schizophrenia patients.
BMC Psychiatry. 2020 May 12;20(1):219. doi: 10.1186/s12888-020-02630-z.
8
[Symptomatic remission and its relationship to social functioning in Tunisian out-patients with schizophrenia].
Encephale. 2019 Feb;45(1):15-21. doi: 10.1016/j.encep.2017.09.005. Epub 2017 Nov 28.
9
Symptomatic remission in previously untreated patients with schizophrenia: 2-year results from the SOHO study.
Psychopharmacology (Berl). 2007 May;191(4):1015-22. doi: 10.1007/s00213-007-0730-2. Epub 2007 Feb 20.
10
Predictors of symptomatic remission in patients with first-episode schizophrenia: a 16years follow-up study.
Compr Psychiatry. 2014 May;55(4):778-84. doi: 10.1016/j.comppsych.2013.12.011. Epub 2013 Dec 18.
本文引用的文献
1
Course and predictors of symptomatic remission in late-life schizophrenia: A 5-year follow-up study in a Dutch psychiatric catchment area.
Schizophr Res. 2019 Jul;209:179-184. doi: 10.1016/j.schres.2019.04.025. Epub 2019 May 9.
2
Positive psychiatry comes of age.
Int Psychogeriatr. 2018 Dec;30(12):1735-1738. doi: 10.1017/S1041610218002211.
3
Childhood Adversity and Schizophrenia: The Protective Role of Resilience in Mental and Physical Health and Metabolic Markers.
J Clin Psychiatry. 2018 May/Jun;79(3). doi: 10.4088/JCP.17m11776.
4
Why We Need Positive Psychiatry for Schizophrenia and Other Psychotic Disorders.
Schizophr Bull. 2017 Mar 1;43(2):227-229. doi: 10.1093/schbul/sbw184.
5
Positive mental health in schizophrenia and healthy comparison groups: relationships with overall health and biomarkers.
Aging Ment Health. 2018 Mar;22(3):354-362. doi: 10.1080/13607863.2016.1251572. Epub 2016 Nov 11.
6
Wellness within illness: happiness in schizophrenia.
Schizophr Res. 2014 Oct;159(1):151-6. doi: 10.1016/j.schres.2014.07.027. Epub 2014 Aug 18.
7
Divergent trajectories of physical, cognitive, and psychosocial aging in schizophrenia.
Schizophr Bull. 2011 May;37(3):451-5. doi: 10.1093/schbul/sbr026.
8
Symptomatic remission and associated factors in a catchment area based population of older patients with schizophrenia.
Schizophr Res. 2011 Mar;126(1-3):237-44. doi: 10.1016/j.schres.2010.09.003.
9
Neuroprotective effects of cognitive enhancement therapy against gray matter loss in early schizophrenia: results from a 2-year randomized controlled trial.
Arch Gen Psychiatry. 2010 Jul;67(7):674-82. doi: 10.1001/archgenpsychiatry.2010.63. Epub 2010 May 3.
10
Is serum brain-derived neurotrophic factor a biomarker for cognitive enhancement in schizophrenia?
Biol Psychiatry. 2009 Sep 15;66(6):549-53. doi: 10.1016/j.biopsych.2009.02.017. Epub 2009 Apr 15.
Zotero 插件